Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 556 AL 570

The Role of HSF1 Protein in Malignant Transformation

Šimončík O, Pastorek M, Vojtěšek B, Müller P.

Klin Onkol. 2018 Winter;31(Suppl 2):55-62. doi: 10.14735/amko20182S55.

Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms

Goodson AB, Cantrell MA, Shaw RF, Lund BC.

J Manag Care Spec Pharm. 2018 Jan;24(1):65-72. doi: 10.18553/jmcp.2018.24.1.65.

Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review

Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):30-42. doi: 10.5056/jnm17105.

Validated multi-step approach for in vivo recording and analysis of optogenetically evoked glutamate in the mouse globus pallidus

Viereckel T, Konradsson-Geuken Å, Wallén-Mackenzie Å.

J Neurochem. 2018 Apr;145(2):125-138. doi: 10.1111/jnc.14288. Epub 2018 Mar 13.

Network connectivity determines cortical thinning in early Parkinson's disease progression

Yau Y, Zeighami Y, Baker TE, Larcher K, Vainik U, Dadar M, Fonov VS, Hagmann P, Griffa A, Mišić B, Collins DL, Dagher A.

Nat Commun. 2018 Jan 2;9(1):12. doi: 10.1038/s41467-017-02416-0.

Neuropathology of autonomic dysfunction in synucleinopathies

Coon EA, Cutsforth-Gregory JK, Benarroch EE.

Mov Disord. 2018 Mar;33(3):349-358. doi: 10.1002/mds.27186. Epub 2018 Jan 3.

Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists

Elson MJ, Stevenson EA, Feldman BA, Lim J, Beck CA, Beran DB, Schmidt PN, Biglan KM, Simone R, Willis AW, Dorsey ER, Boyd CM.

Telemed J E Health. 2018 Sep;24(9):722-724. doi: 10.1089/tmj.2017.0210. Epub 2018 Jan 3.

Cardiac manifestations of PRKAG2 mutation

Banankhah P, Fishbein GA, Dota A, Ardehali R.

BMC Med Genet. 2018 Jan 3;19(1):1. doi: 10.1186/s12881-017-0512-6.

Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough

Munoz DG, Fujioka S.

Neurology. 2018 Jan 30;90(5):205-206. doi: 10.1212/WNL.0000000000004898. Epub 2018 Jan 3.

Electrophysiology of Olfactory and Optic Nerve in Outpatient and Intraoperative Settings

Hariharan P, Balzer JR, Anetakis K, Crammond DJ, Thirumala PD.

J Clin Neurophysiol. 2018 Jan;35(1):3-10. doi: 10.1097/WNP.0000000000000416.

A refined concept: α-synuclein dysregulation disease

Mochizuki H, Choong CJ, Masliah E.

Neurochem Int. 2018 Oct;119:84-96. doi: 10.1016/j.neuint.2017.12.011. Epub 2018 Jan 2.

Neurotrophic factors hold promise for the future of Parkinson's disease treatment: is there a light at the end of the tunnel?

Nasrolahi A, Mahmoudi J, Akbarzadeh A, Karimipour M, Sadigh-Eteghad S, Salehi R, Farhoudi M.

Rev Neurosci. 2018 Jul 26;29(5):475-489. doi: 10.1515/revneuro-2017-0040.

Serotonergic targets for the treatment of L-DOPA-induced dyskinesia

Lanza K, Bishop C.

J Neural Transm (Vienna). 2018 Aug;125(8):1203-1216. doi: 10.1007/s00702-017-1837-1. Epub 2018 Jan 5.

Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies

Politi C, Ciccacci C, Novelli G, Borgiani P.

Neuromolecular Med. 2018 Mar;20(1):1-17. doi: 10.1007/s12017-017-8473-7. Epub 2018 Jan 5.

Pathological role of lipid interaction with α-synuclein in Parkinson's disease

Suzuki M, Sango K, Wada K, Nagai Y.

Neurochem Int. 2018 Oct;119:97-106. doi: 10.1016/j.neuint.2017.12.014. Epub 2018 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias